Share This
Create Your Own Business Intelligence Website
 
Input the stock code or the company name     Search  

<00656.HK> - Fosun International Limited

 
 
 Basic Datum
Company name Lot P/E P/B EPS DPS
FOSUN INTL 500 12.46 1.3813 1.3224 0.21
Profile Information Data Financial Ratios Profit Loss Cash Flow Balance Earnings Dividend
 
 
 
 Company Rating
Date Broker Company name Rating Target
≫More
 
 Company performance - Published
Date Company name Turnover* Profit* % Dividend
≫More
 
 Comment
2021-02-05 FOSUNI 5 1/4 03/23/22發行規模14億美元,息票率5.25%,於2022年3月23日到期,ISIN:XS1581103428。該票據由復星國際有限公司(FOSUN INTERNATIONAL LIMITED,簡稱「復星國際」,00656.HK)提供擔保。
 
2021-02-19 此外,馬雲的一些老朋友也通過各種投資工具得到螞蟻集團的股權,其中包括一些中國富豪,例如房地產大亨盧志強、網路游戲公司董事長史玉柱,以及復星國際共同創辦人郭廣昌。報導稱,習近平並不樂見螞蟻集團的上市為太子黨輸送巨大利益。在習近平看來,這無疑會擴大收入差距,損害他消除貧困的努力。江志成和報導中提到的其他螞蟻集團投資者均不予置評。
 
2021-02-19 螞蟻能否重啟IPO,如今還不在北京高層議程內。據直言,紅色資本家成為螞蟻「戰略投資者」,馬雲把部分股權分給中國國有實體如社保基金、中投公司、幾大保險公司,這些投資者則協助螞蟻順利通過各級證券管控機構上市審查,一個月就獲批准。馬雲老朋友也通過各種投資工具得到股權,包括房地產大亨泛海控股創辦人盧志強、游戲商巨人網絡董事長史玉柱、復星國際共同創辦人郭廣昌等中國富豪。
 
2021-03-05 復星醫藥和復星國際的疫苗布局就此開始。交給回愛民所在的復星全球研發中心的第一步,是梳理所有的疫苗技術路線。第一代的滅活疫苗、減毒疫苗;第二代的蛋白疫苗,載體疫苗;第三代的核酸疫苗。
 
 
 Top Gain / Loss Show All Charts 
 
 Value
Name Updated Value Change Change %
HSI 03-04 15:48 29298.8  581.67  1.95%
FOSUN INTL 03-05 16:08 11.28  0.1  0.89%
≫More
 
 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2021Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.